Literature DB >> 27026592

Opposing actions of the synapse-associated protein of 97-kDa molecular weight (SAP97) and Disrupted in Schizophrenia 1 (DISC1) on Wnt/β-catenin signaling.

M Boccitto1, S Doshi2, I P Newton3, I Nathke3, R Neve4, F Dong5, Y Mao5, J Zhai6, L Zhang6, R Kalb7.   

Abstract

It has been suggested that synapse-associated protein of 97-kDa molecular weight (SAP97) is a susceptibility factor for childhood and adult neuropsychiatric disorders. SAP97 is a scaffolding protein that shares direct and indirect binding partners with the Disrupted in Schizophrenia 1 (DISC1) gene product, a gene with strong association with neuropsychiatric disorders. Here we investigated the possibility that these two proteins converge upon a common molecular pathway. Since DISC1 modifies Wnt/β-catenin signaling via changes in glycogen synthase kinase 3 beta (GSK3β) phosphorylation, we asked if SAP97 impacts Wnt/β-catenin signaling and GSK3β phosphorylation. We find that SAP97 acts as inhibitor of Wnt signaling activity and can suppress the stimulatory effects of DISC1 on β-catenin transcriptional activity. Reductions in SAP97 abundance also decrease GSK3β phosphorylation. In addition, we find that over expression of DISC1 leads to an increase in the abundance of SAP97, by inhibiting its proteasomal degradation. Our findings suggest that SAP97 and DISC1 contribute to maintaining Wnt/β-catenin signaling activity within a homeostatic range by regulating GSK3β phosphorylation.
Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DISC1; SAP97; Wnt; autism; schizophrenia; β-catenin

Mesh:

Substances:

Year:  2016        PMID: 27026592      PMCID: PMC4853273          DOI: 10.1016/j.neuroscience.2016.03.048

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  33 in total

1.  NMDA-receptor activation induces calpain-mediated beta-catenin cleavages for triggering gene expression.

Authors:  Kentaro Abe; Masatoshi Takeichi
Journal:  Neuron       Date:  2007-02-01       Impact factor: 17.173

2.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 3.  Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: case report and review.

Authors:  Fabiola Quintero-Rivera; Pantea Sharifi-Hannauer; Julian A Martinez-Agosto
Journal:  Am J Med Genet A       Date:  2010-10       Impact factor: 2.802

4.  Microdeletions of 3q29 confer high risk for schizophrenia.

Authors:  Jennifer Gladys Mulle; Anne F Dodd; John A McGrath; Paula S Wolyniec; Adele A Mitchell; Amol C Shetty; Nara L Sobreira; David Valle; M Katharine Rudd; Glen Satten; David J Cutler; Ann E Pulver; Stephen T Warren
Journal:  Am J Hum Genet       Date:  2010-08-13       Impact factor: 11.025

5.  The role of SAP97 in synaptic glutamate receptor dynamics.

Authors:  Mackenzie A Howard; Guillermo M Elias; Laura A B Elias; Wojciech Swat; Roger A Nicoll
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-03       Impact factor: 11.205

6.  An association analysis of synapse-associated protein 97 (SAP97) gene in schizophrenia.

Authors:  Junko Sato; Dai Shimazu; Naoki Yamamoto; Toru Nishikawa
Journal:  J Neural Transm (Vienna)       Date:  2008-07-30       Impact factor: 3.575

7.  SZGR: a comprehensive schizophrenia gene resource.

Authors:  P Jia; J Sun; A Y Guo; Z Zhao
Journal:  Mol Psychiatry       Date:  2010-05       Impact factor: 15.992

Review 8.  The DISC locus in psychiatric illness.

Authors:  J E Chubb; N J Bradshaw; D C Soares; D J Porteous; J K Millar
Journal:  Mol Psychiatry       Date:  2007-10-02       Impact factor: 15.992

9.  Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling.

Authors:  Yingwei Mao; Xuecai Ge; Christopher L Frank; Jon M Madison; Angela N Koehler; Mary Kathryn Doud; Carlos Tassa; Erin M Berry; Takahiro Soda; Karun K Singh; Travis Biechele; Tracey L Petryshen; Randall T Moon; Stephen J Haggarty; Li-Huei Tsai
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

10.  GluR1 controls dendrite growth through its binding partner, SAP97.

Authors:  Weiguo Zhou; Lei Zhang; Xiong Guoxiang; Jelena Mojsilovic-Petrovic; Kogo Takamaya; Rita Sattler; Richard Huganir; Robert Kalb
Journal:  J Neurosci       Date:  2008-10-08       Impact factor: 6.167

View more
  4 in total

Review 1.  Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.

Authors:  Mahdi Rizk; Zahraa Saker; Hisham F Bahmad; Sanaa Nabha; Hayat Harati; Youssef Fares
Journal:  Mol Biol Rep       Date:  2021-03-01       Impact factor: 2.316

Review 2.  Wnt signaling networks in autism spectrum disorder and intellectual disability.

Authors:  Vickie Kwan; Brianna K Unda; Karun K Singh
Journal:  J Neurodev Disord       Date:  2016-12-05       Impact factor: 4.025

3.  Dlg1 activates beta-catenin signaling to regulate retinal angiogenesis and the blood-retina and blood-brain barriers.

Authors:  Chris Cho; Yanshu Wang; Philip M Smallwood; John Williams; Jeremy Nathans
Journal:  Elife       Date:  2019-05-08       Impact factor: 8.140

4.  A prenatal interruption of DISC1 function in the brain exhibits a lasting impact on adult behaviors, brain metabolism, and interneuron development.

Authors:  Dazhi Deng; Chongdong Jian; Ling Lei; Yijing Zhou; Colleen McSweeney; Fengping Dong; Yilun Shen; Donghua Zou; Yonggang Wang; Yuan Wu; Limin Zhang; Yingwei Mao
Journal:  Oncotarget       Date:  2017-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.